1.6350
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,831.0000
-39,350.0000
-45,456.0000
6,806.0000
-10,776.0000
Investing Cash Flow
-66,943.0000
16,430.0000
-16,542.0000
8,676.0000
9,618.0000
Financing Cash Flow
122,299.0000
25,155.0000
43,049.0000
30,711.0000
15,428.0000
End Cash Position
70,337.0000
54,031.0000
54,816.0000
73,537.0000
27,449.0000
Capital Expenditure
-117.0000
-45.0000
-440.0000
-1,334.0000
-514.0000
Issuance of Capital Stock
128,679.0000
25,329.0000
43,239.0000
30,922.0000
15,830.0000
Repayment of Debt
-189.0000
-174.0000
-190.0000
-211.0000
-402.0000
Free Cash Flow
-43,948.0000
-39,395.0000
-45,896.0000
5,472.0000
-11,290.0000
12/31/2020 - 9/25/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROQ.L Roquefort Therapeutics plc
3.6500
-9.88%
OBI.L Ondine Biomedical Inc.
9.00
0.00%
OBD.L Oxford BioDynamics Plc
0.9110
-8.90%
CRGX CARGO Therapeutics, Inc.
13.50
-4.93%
PSTX Poseida Therapeutics, Inc.
9.50
0.00%
BPTH Bio-Path Holdings, Inc.
0.9500
-2.92%
ATYR aTyr Pharma, Inc.
3.5300
-5.61%
ALNY Alnylam Pharmaceuticals, Inc.
237.98
-1.07%
CMRX Chimerix, Inc.
3.2500
-6.88%
ALLO Allogene Therapeutics, Inc.
2.0550
-12.55%